Abstract
Access to high affinity, high magnetic susceptibility antibody-nanoparticle combinations specific to target cell populations is important for isolation of low frequency cells or cells expressing low level of antigenic markers. A specialized instrument (Cell Tracking Velocimeter, CTV) to measure single cell magnetophoretic mobility (MM) on large cell sample sizes (in thousands) was developed in our laboratories to determine effects of magnetic cell labeling. First, using a hematopoietic progenitor cell line, KG-1a (ATCC, Manassas, VA) seven different CD34 monoclonal antibody and nanoparticles combinations were tested for highest MM: Progenitor KitTM (Miltenyi Biotec, CA) showed the highest MM (2.14±0.31 mm3/T-A-s with 95% confidence). Second, the specificity of the Kit for labeling of progenitor cells in clinical leukapheresis samples was determined by comparing CTV-measured frequency of cells moving in the magnetic field with the flow cytometry (FCM) measured frequency of cells expressing CD34 marker (n=6, r2=0.87). Third, clinical leukapheresis samples labeled with the Kit were enriched for CD34+ cells by continuous magnetophoresis and assayed by CTV and FCM. The results show that the cell MM and the performance of the magnetic separation protocol depend on selection of the magnetic labeling reagent.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
